Statins: a role in breast cancer therapy?

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Statins are widely used to treat hypercholesterolemia and reduce cardiovascular events.
• They inhibit HMGCR, the rate-limiting enzyme in cholesterol biosynthesis.
• Beyond cholesterol reduction, statins exhibit pleiotropic effects, including potential anti-cancer activity.

Purpose of the Study:

• To review the evidence for statins' anti-cancer activity, particularly in breast cancer.
• To discuss the potential mechanisms underlying statins' effects on cancer cells.
• To highlight the growing number of clinical trials and the need for biomarker discovery in breast cancer treatment.

Main Methods:

• Review of preclinical, epidemiological, and clinical evidence on statins and breast cancer.
• Analysis of ongoing and proposed clinical trials investigating statins in breast cancer.
• Discussion of potential mechanisms of action and the importance of biomarkers.

Main Results:

• Preclinical and epidemiological studies suggest statins impair breast cancer cell proliferation and reduce recurrence risk.
• Numerous clinical trials are investigating the efficacy of statins in various breast cancer settings.
• Biomarkers predictive of statin response are crucial for future adjuvant therapy trials.

Conclusions:

• Statins possess anti-cancer properties, particularly relevant to breast cancer.
• Further clinical investigation is warranted to establish statins' role in breast cancer treatment.
• Identifying predictive biomarkers will optimize patient selection for statin therapy.